MTOR and cancer: Concerning Metformin, many mechanisms of anti-cancer activity have been proposed, such as modulation of immunological and/or anti-inflammatory responses, inhibition of mTOR, and inhibition of the insulin signals and glucose synthesis via respiratory-chain complex I blockage [94,96,97,98,99].